Jury Begins Deliberations In Suit Over AbbVie's AndroGel
A man who claims he had a heart attack after using AbbVie Inc.'s testosterone replacement therapy drug AndroGel made his final plea to the Illinois federal jury hearing his case Friday,...To view the full article, register now.
Already a subscriber? Click here to view full article